nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in T-cell co-receptor biology and cancer immunotherapy
|
Rudd, Christopher E. |
|
2019 |
42 |
C |
p. |
artikel |
2 |
CEACAM1 structure and function in immunity and its therapeutic implications
|
Kim, Walter M. |
|
2019 |
42 |
C |
p. |
artikel |
3 |
Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment
|
Bastien, Jean-Philippe |
|
2019 |
42 |
C |
p. |
artikel |
4 |
Common gamma chain cytokines and CD8 T cells in cancer
|
Shourian, Mitra |
|
2019 |
42 |
C |
p. |
artikel |
5 |
Corrigendum to “Chemokines sound the alarmin: The role of atypical chemokine receptors in inflammation and cancer” [Semin. Immunol. 38 (2018) 63–71]
|
Borroni, Elena Monica |
|
2019 |
42 |
C |
p. |
artikel |
6 |
CTLA-4 (CD152): A versatile receptor for immune-based therapy
|
Lingel, Holger |
|
2019 |
42 |
C |
p. |
artikel |
7 |
Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications
|
Krueger, Janna |
|
2019 |
42 |
C |
p. |
artikel |
8 |
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor
|
Ruffo, Elisa |
|
2019 |
42 |
C |
p. |
artikel |
9 |
Targeting the adenosine pathway for cancer immunotherapy
|
Hammami, Akil |
|
2019 |
42 |
C |
p. |
artikel |
10 |
Tim-3: A co-receptor with diverse roles in T cell exhaustion and tolerance
|
Tang, Ruihan |
|
2019 |
42 |
C |
p. |
artikel |
11 |
VISTA: A novel immunotherapy target for normalizing innate and adaptive immunity
|
ElTanbouly, Mohamed A. |
|
2019 |
42 |
C |
p. |
artikel |